# Moderato System: A Double-Blind Randomized Trial Ver 1.1

> **NCT02837445** · NA · UNKNOWN · sponsor: **BackBeat Medical Inc** · enrollment: 170 (estimated)

## Conditions studied

- Hypertension Resistant to Conventional Therapy
- Bradycardia
- Atrioventricular Block

## Interventions

- **DEVICE:** PHC ON
- **DEVICE:** PHC OFF

## Key facts

- **NCT ID:** NCT02837445
- **Lead sponsor:** BackBeat Medical Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07-12
- **Primary completion:** 2019-08
- **Final completion:** 2023-03
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2022-12-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02837445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02837445, "Moderato System: A Double-Blind Randomized Trial Ver 1.1". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02837445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
